Skip to main content
. 2021 Jun 14;21:567. doi: 10.1186/s12879-021-06237-x

Fig. 4.

Fig. 4

Dynamic changes in serial mean ALT (A), AST(B), total bilirubin(C), albumin(D), cholesterol (E), and MELD score (F) in patients treated with tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir in patients with HBV-related ACLF. ETV, entecavir; TAF, tenofovir alafenamide; TDF, tenofovir disoproxil fumarate; ALT, alanine aminotransferase; AST, aspartate Aminotransferase; MELD, Model for End-stage Liver Disease